UBS Group
KMTS

UBS Group’s Kestra Medical Technologies KMTS Stock Holding History

UBS Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.29M Sell
325,838
-23,849
-7% -$499K ﹤0.01% 3652
2026
Q1 		$6.97M Buy
349,687
+79,629
+29% +$1.88M ﹤0.01% 3723
2025
Q4 		$7.16M Buy
270,058
+69,908
+35% +$1.8M ﹤0.01% 3661
2025
Q3 		$4.76M Buy
200,150
+127,026
+174% +$2.27M ﹤0.01% 4093
2025
Q2 		$1.21M Buy
73,124
+27,329
+60% +$597K ﹤0.01% 5276
2025
Q1 		$1.14M Buy
+45,795
New +$1.05M ﹤0.01% 5171

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS Group's KMTS Position: Q2 2026 in Review

UBS Group reduced its Kestra Medical Technologies (KMTS) stake by 6.8% in Q2 2026, selling an estimated $499K and leaving 325,838 shares worth $8.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

UBS Group first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • UBS Group held 325,838 shares of Kestra Medical Technologies worth $8.29M as of Q2 2026.
  • UBS Group sold 23,849 Kestra Medical Technologies shares in Q2 2026, an estimated $499K.
  • Kestra Medical Technologies made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3652 holding.
  • UBS Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.